STOCK BASED COMPENSATION |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| STOCK BASED COMPENSATION |
During the three months ended March 31, 2026 and 2025, the Company did not grant any stock based compensation to employees or consultants.
As of March 31, 2026, the weighted-average remaining contractual life of outstanding and exercisable options is years and years, respectively. As of March 31, 2026, there was approximately $ of compensation expense related to non-vested options that is expected to be recognized over a weighted average period of years.
The aggregate intrinsic value of options outstanding and exercisable at March 31, 2026 is $ and $, respectively. During the three months ended March 31, 2026, the intrinsic value of stock options exercised was $ (2025 - $).
During the year ended December 31, 2025, the Company granted shares as a stock award. The total fair value of the stock award was $350,000 with shares vested upon issuance and shares vest on each anniversary date through 2029. As of March 31, 2026, there was approximately $ of compensation related to the 40,000 non-vested shares of the stock award that is expected to be recognized through 2029.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||